PerkinElmer changed COVID-19 rapid testing with highly sensitive point of care antigen test for mass screening
On Feb. 23, 2021, PerkinElmer announced the launch of the PerkinElmerï¾® COVID-19 Antigen Test for the qualitative detection…
On Feb. 23, 2021, PerkinElmer announced the launch of the PerkinElmerï¾® COVID-19 Antigen Test for the qualitative detection…
On Feb. 22, 2021, the World Health Organization (WHO) and Chubb signed an agreement on behalf of the…
On Feb. 22, 2021, Amyris announced highly promising preliminary data in a pre-clinical study of its ribonucleic acid…
On Feb. 22, 2021, Biohaven Pharmaceutical announced that a hyperimmune globulin mimic (HGM) developed with Biohaven’s proprietary MATE…
On Feb. 22, 2021, Novavax announced it had completed enrollment of PREVENT-19, its pivotal Phase 3 study in…
On Feb. 22, 2021, BD (Becton, Dickinson) and Scanwell Health, a leader in smartphone-enabled at-home medical tests, announced…
On Feb. 26, 2021, Russian authorities reported the detection of influenza A(H5N8) virus infection in seven poultry workers…
On Feb. 19, 2021, the ACT Accelerator partnership welcomed over US$ 4.3 billion of new investments from the…
On Feb. 19, 2021, Johnson & Johnson announced that Janssen-Cilag had submitted for Emergency Use Listing (EUL) to…
On Feb. 19, 2021, BioNTech announced the submission of new data to the FDA demonstrating the stability of…
On Feb. 19, 2021, Luminex announced that it had received $11.3 million in funding from the Biomedical Advanced…
On Feb. 18, 2021, scientists at the University of Oxford announced that the Randomised Evaluation of COVID-19 Therapy…
On Feb. 18, 2021, Agilent Technologies announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay…
On Feb. 18, 2021, Novavax and announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to…
On Feb. 18, 2021, Washington University pediatric infectious diseases doctors announced plans to launch clinical trials in the…
On Feb. 18, 2021, Pacific Biosciences announced that Labcorp had increased its commitment to highly accurate HiFi sequencing…
On Feb. 18, 2021, Pfizer and BioNTech announced that the first participants hadbeen dosed in a global Phase…
On Feb. 17, 2021, the NIH annunced funding of a study to evaluate the effects of remdesivir in…
On Feb. 17, 2021, Novartis announced that it had entered into a grant agreement with the Bill &…
On Feb. 17, 2021, TGen, an affiliate of City of Hope announced that it had found a way…
On Feb. 17, 2021, Moderna announced that the European Commission had purchased an additional 150 million doses of…
On Feb. 17, 2021, Altimmune announced that the FDA had cleared the Companyï¾’s Investigational New Drug (IND) application…
On Feb. 17, 2021, LabCorp announced the availability of a new laboratory-based antigen test that will help doctors…
On Feb. 17, 2021, BioNTech announced an agreement with the European Commission (EC) to supply an additional 200…
On Feb. 17, 2021, Immunic announced that its lead asset, IMU-838, the company’s selective oral DHODH inhibitor, had…
On Feb. 17, 2021, BioNTech announced results from an in vitro study that provided additional data on the…
On Apr. 23, 2015, researchers announced that mammoth teeth preserved in eastern Siberian permafrost produced the oldest ancient…
On Feb. 16, 2021, in a study led by National Institutes of Health researchers, scientists found that five…
On Feb. 16, 2021, Anixa Biosciences announced that animal testing had commenced with two proprietary compounds that have…
On Feb. 16, 2021, XPhyto and 3a-diagnostics announced that all actions and procedures required for its European regulatory…